دورية أكاديمية
Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study
| العنوان: | Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study |
|---|---|
| المؤلفون: | Gogas, H., Dréno, B., Larkin, J., Demidov, L., Stroyakovskiy, D., Eroglu, Z., Francesco Ferrucci, P., Pigozzo, J., Rutkowski, P., Mackiewicz, J., Rooney, I., Voulgari, A., Troutman, S., Pitcher, B., Guo, Y., Yan, Y., Castro, M., Mulla, S., Flaherty, K., Arance, A. |
| المساهمون: | F. Hoffmann-La Roche, Genentech Inc |
| المصدر: | Annals of Oncology ; volume 32, issue 3, page 384-394 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2021 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2020.12.004 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2020.12.004Test https://api.elsevier.com/content/article/PII:S092375342043203X?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S092375342043203X?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.B42212F |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2020.12.004 |
|---|